FDA Approves BYDUREON™ -- The First and Only Once-Weekly Treatment for Type 2 Diabetes - StreetInsider.comBYDUREON is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes in multiple ... The risk of getting low blood sugar is higher if BYDUREON ...FDA approves Jentadueto™ (linagliptin/metformin hydrochloride) tablets for the treatment of adult patients with type 2 diabetes - SYS-CON Media (press release)JENTADUETO is a prescription medication used along with diet and exercise to improve glycemic control in adults ... "Most people with type 2 diabetes require more than one medication to help lower their blood sugar, due to the complex nature of type ...Self-Monitoring Not Helpful for Type 2 Diabetes - Medscape NewsFebruary 6, 2012 — Self-monitoring of blood glucose (SMBG) has very little effect on glycemic control in patients ... This systemic review suggests that patients with type 2 diabetes are not using SMBG to adjust their diet and lifestyle.